Hospital Arnau Vilanova Valencia has developed a harness axillary that fewer seroma after
intervention. In addition, the center uses metallic markers to locate small tumors that favor a
faster recovery and enhances the autonomy of patients.
The system devised in the Arnau Vilanova favors a faster recovery and improves autonomy of
patients.
Functional Unit of Pathology Mammary Hospital Arnau Vilanova Valencia has developed a compression
system that axillary fewer seroma (accumulation of fluid in the armpit after a lymphadenectomy)
after surgery on the armpit in breast cancer.
The system, which has been devised by the physicians of this unit and designed by orthopedist
Amparo Sotos, is a kind of belt bandolera which has been incorporated into an elastic compression
that fits over the hollow axillary, which avoids postoperative complications arising from this
type of intervention and improving the autonomy of patients.
Through this system is achieved by reducing both the number of patients with seroma and punctures
for the evacuation of the seroma and reduces the increase in linfedemas, discomfort and control
posquirúrgico.
Another initiative that has carried out this unit to facilitate the recovery of patients with
breast cancer and improve their quality of life is the signing of an agreement with the
Rehabilitation Service for the last of each month to receive necessary guidance in the
rules of hygiene, gymnastics and general advice to be followed as part of the prevention of
lymphedema.
One of the problems that are facing professionals dedicated to this disease is the loss of
references for locating cancers minimal (less than one centimeter) and the loss of referrals from
the area where the tumor is located behind the implementation of schemes neoadjuvant
chemotherapy.
The placement of a harpoon prior to surgery facilitates intervention, as it geared towards the
point where the injury is not palpable or toward the marker has been placed before chemotherapy.
Sunday, March 9, 2008
Validate a pilot new services to citizens through
The Sector Barbastro is a pioneer in the application of new technologies in healthcare, stressing
among its telemedicine project, which aims to bring assistance to the population dispersed. Thus,
in June the town oscense will host a European Union forum on Telemedicine and their applications
in health practice. Specifically, the meeting will be held at the Congress and Exhibition Centre
For some years now, in Barbastro projects are being developed in collaboration with other
European and national institutions. Through the European Commission is participating in the pilot
project Optimum Health, which are also involved teams Danes and Italians. This is based on the
videoconference, is currently deployed throughout Aragon in its third phase.
In addition, teams of Barbastro are developing three other European projects-Eurogene, Dreaming
and SUP (Safety and Emergency Services in the Pyrenees) - joined by two other nationals linked to
the Ministry of Industry (Realth and Ispamat).
Delegations of the partners of the four European projects will meet in June in Barbastro. They
will be joined by members of two other projects, including Europeans, Better Breathing and Mpower
to encourage the sharing of knowledge among all and identify potential synergies to work
together.
During the forum, there will be informational presentations, workshops and hands-on workshops and
technology, with the main objective of creating awareness of the various telemedicine projects
Europeans. In addition, the organization of this meeting aims to further the objectives of each
plan, learn new technologies applied in this field, facilitate knowledge among those involved and
involve more professional. Are expected to attend some personalities from the world of
European telemedicine.
It has created a website which centralizes information on this
event and which is subsequently planned to publish the results.
Of the four European projects underway in Barbastro, highlights the Optimum Health, which seeks
the deployment of videoconferencing services in Aragon. The European Union contributes to the
financing.
Also with European investment projects are being developed and Eurogene Dreaming. The first aims
to provide support services for the elderly, such as monitoring and alarm manuals or condition
, as well as other services not essential for its technological autonomy
as visits by nurses and social workers, psychological support, delivery of meals , transportation
or special household. In total, the European budget for Barbastro is euros.
As to Eurogene, this project aims to create an international platform of preventive care by
incorporating genetic analysis of individual and his or her lifestyle. This has provided
euros from European funds.
On the other hand, Barbastro is developing two projects of the Ministry of Industry, Tourism and
Trade. This is the Realth (Remote Health), which works to achieve greater prosperity by improving
health services and optimizing the management of health care resources, and ISPAMAT, where the
sector Barbastro collaborating to validate a pilot new services to citizens through DTT in Fraga.
The budgets amounted t euros respectively.
among its telemedicine project, which aims to bring assistance to the population dispersed. Thus,
in June the town oscense will host a European Union forum on Telemedicine and their applications
in health practice. Specifically, the meeting will be held at the Congress and Exhibition Centre
For some years now, in Barbastro projects are being developed in collaboration with other
European and national institutions. Through the European Commission is participating in the pilot
project Optimum Health, which are also involved teams Danes and Italians. This is based on the
videoconference, is currently deployed throughout Aragon in its third phase.
In addition, teams of Barbastro are developing three other European projects-Eurogene, Dreaming
and SUP (Safety and Emergency Services in the Pyrenees) - joined by two other nationals linked to
the Ministry of Industry (Realth and Ispamat).
Delegations of the partners of the four European projects will meet in June in Barbastro. They
will be joined by members of two other projects, including Europeans, Better Breathing and Mpower
to encourage the sharing of knowledge among all and identify potential synergies to work
together.
During the forum, there will be informational presentations, workshops and hands-on workshops and
technology, with the main objective of creating awareness of the various telemedicine projects
Europeans. In addition, the organization of this meeting aims to further the objectives of each
plan, learn new technologies applied in this field, facilitate knowledge among those involved and
involve more professional. Are expected to attend some personalities from the world of
European telemedicine.
It has created a website which centralizes information on this
event and which is subsequently planned to publish the results.
Of the four European projects underway in Barbastro, highlights the Optimum Health, which seeks
the deployment of videoconferencing services in Aragon. The European Union contributes to the
financing.
Also with European investment projects are being developed and Eurogene Dreaming. The first aims
to provide support services for the elderly, such as monitoring and alarm manuals or condition
, as well as other services not essential for its technological autonomy
as visits by nurses and social workers, psychological support, delivery of meals , transportation
or special household. In total, the European budget for Barbastro is euros.
As to Eurogene, this project aims to create an international platform of preventive care by
incorporating genetic analysis of individual and his or her lifestyle. This has provided
euros from European funds.
On the other hand, Barbastro is developing two projects of the Ministry of Industry, Tourism and
Trade. This is the Realth (Remote Health), which works to achieve greater prosperity by improving
health services and optimizing the management of health care resources, and ISPAMAT, where the
sector Barbastro collaborating to validate a pilot new services to citizens through DTT in Fraga.
The budgets amounted t euros respectively.
Albacete collaborates with research groups
Albacete looking 'therapies to the letter' in cancer treatment
PROGRESS. Treatment of radiotherapy. THE TRUTH
Achieve 'therapies to the letter' for cancer treatment tailored to the characteristics of each
patient. That is the goal you are working in the Laboratory of Molecular Oncology Regional Center
for Biomedical Research (CRIB) led by Dr. Ricardo Sanchez.
This team has achieved a major breakthrough in research on molecular basis of transformation,
diagnosis and treatment of cancer, as it relates in particular to the role of signalling pathways
acting on the response to chemotherapy and radiotherapy treatments , trying to establish the
value as markers of a group of proteins and analyze how specific the role of these routes as a
means of resistance to the therapy against oncological diseases.
"We are trying to answer a question which is a classic in cancer, which focuses on finding
answers on the reasons why two people with the same tumor, the same age and habits respond or not
chemotherapy treatments with the aim, among others, to avoid in its day and if side effects,
bearing in mind that chemotherapy is a very aggressive therapy with side effects and very toxic.
To answer this question we have focused our research on a group of genes known as signalling that
are responsible for transmitting information from extracellular to intracellular environment,
"said Dr. Sanchez. In this way, are investigating changes in patterns of gene expression, ie stop
expressing genes and start others to do so.
Implication
What will be the implications on a practical level of these findings? The outcome of this
investigation may write to the detection of proteins in the biopsies of patients to medical
oncologists to convey information about what will happen. "If we can determine that a specific
protein will activate, the specialist in Oncology will have more concrete data response in the
treatment of malignant tumors, and implement the procedures and substances most appropriate for
each particular case and remove side effects" said Dr. Sanchez.
He added that the ultimate objective of the research is to "get what we might call a 'therapy to
the letter' because our aim is to determine that based on a series of genetic and biochemical
parameters we predict the patient's response to treatment that it administers, "said Dr. Sanchez.
At present, what is being done is to administer a cocktail of drugs and is the respondent to act
accordingly. "Our research aims, therefore, to avoid this test phase and testing and thus go to
the drug that can operate or have more chances to do so, which represents a gain of time in
treatment of cancer is a very relevant. This is the basis of our scientific study. Now, we have
discovered a protein that is critical to the resistance to therapy for a type of leukemia,
showing that the activation of this protein blocks the effect of the drug. If you translate these
findings into clinical practice, would mean that if detected this protein is not to administer
the drug and also eliminates the side effects, "explained Ricardo Sanchez.
The laboratory Albacete collaborates with research groups such as the Cancer Center of Salamanca
or the Institute for Biomedical Research Madrid and maintains contacts in the United States and
Australia to exchange experiences. we may know whether the proteins with which we are working are good predictive markers of the patient's ....
PROGRESS. Treatment of radiotherapy. THE TRUTH
Achieve 'therapies to the letter' for cancer treatment tailored to the characteristics of each
patient. That is the goal you are working in the Laboratory of Molecular Oncology Regional Center
for Biomedical Research (CRIB) led by Dr. Ricardo Sanchez.
This team has achieved a major breakthrough in research on molecular basis of transformation,
diagnosis and treatment of cancer, as it relates in particular to the role of signalling pathways
acting on the response to chemotherapy and radiotherapy treatments , trying to establish the
value as markers of a group of proteins and analyze how specific the role of these routes as a
means of resistance to the therapy against oncological diseases.
"We are trying to answer a question which is a classic in cancer, which focuses on finding
answers on the reasons why two people with the same tumor, the same age and habits respond or not
chemotherapy treatments with the aim, among others, to avoid in its day and if side effects,
bearing in mind that chemotherapy is a very aggressive therapy with side effects and very toxic.
To answer this question we have focused our research on a group of genes known as signalling that
are responsible for transmitting information from extracellular to intracellular environment,
"said Dr. Sanchez. In this way, are investigating changes in patterns of gene expression, ie stop
expressing genes and start others to do so.
Implication
What will be the implications on a practical level of these findings? The outcome of this
investigation may write to the detection of proteins in the biopsies of patients to medical
oncologists to convey information about what will happen. "If we can determine that a specific
protein will activate, the specialist in Oncology will have more concrete data response in the
treatment of malignant tumors, and implement the procedures and substances most appropriate for
each particular case and remove side effects" said Dr. Sanchez.
He added that the ultimate objective of the research is to "get what we might call a 'therapy to
the letter' because our aim is to determine that based on a series of genetic and biochemical
parameters we predict the patient's response to treatment that it administers, "said Dr. Sanchez.
At present, what is being done is to administer a cocktail of drugs and is the respondent to act
accordingly. "Our research aims, therefore, to avoid this test phase and testing and thus go to
the drug that can operate or have more chances to do so, which represents a gain of time in
treatment of cancer is a very relevant. This is the basis of our scientific study. Now, we have
discovered a protein that is critical to the resistance to therapy for a type of leukemia,
showing that the activation of this protein blocks the effect of the drug. If you translate these
findings into clinical practice, would mean that if detected this protein is not to administer
the drug and also eliminates the side effects, "explained Ricardo Sanchez.
The laboratory Albacete collaborates with research groups such as the Cancer Center of Salamanca
or the Institute for Biomedical Research Madrid and maintains contacts in the United States and
Australia to exchange experiences. we may know whether the proteins with which we are working are good predictive markers of the patient's ....
Perpendicular to these guides light channels fluídicos
Investigators Nanophotonics Technology Center (NTC) of the Polytechnic University are developing
a sensor biochemist from 'user-friendly, cost-effective and fast', which will be used to detect
various diseases simultaneously from a small sample of blood.
This was reported today by the principal investigator, Dr. Daniel Hill, who has said that the
European project SABIO (Ultrahigh sensitivity Slot-wAveguide BIOsensor on a highly integrated
chip for simultaneous diagnosis of multiple diseases) is part of the Sixth Framework Programme,
began in January 2006 and lasts for three years.
The investigator stated that the objective of the research is to be able to detect any health
center or hospital Hepatitis B and C, citomeglovirus and liver cancer fast reliable without
having to send the sample to a laboratory , thus saving money and energy.
Daniel Hill, the project coordinator, has indicated that it only requires a simple drop of blood
and waiting for minutes to get the results.
In addition, this instrument will be compact and automated, thus easy to handle for a person with
little technical knowledge.
The 'box' or platform where the sample is introduced, incorporating the different components that
research units involved in SABIO have developed, primarily a chip photonics, a system to control
entry and exit lighting, anti-vibration system and another control the temperature, and that any
alteration of conditions can affect the outcome.
The chip that analyzes the sample is composed of components of nanometer size (1 millimeter =
which explains that with a single drop of blood will be able to obtain
reliable results.
Moreover, compared with the sensors currently available on the market, this device includes many
more areas of detection, thus generates a lot of data points which translates into greater
sensitivity in the measurement of a greater number of diseases with a sample small.
'There is no technology that can do so many tests in an area so small,' said Daniel Hill.
By reducing the sample, also reduces the amount of reagents used thereby lowering the process.
The design of the chip or biochemical sensor is the most complex.
It's made with silicon, the same material which manufactured electronic microchips phones or
computers, but transmits light rather than electricity.
This is possible thanks to the incorporation of a series of nanoguías light or 'guides slotted'
(slot-waveguides) that channel light.
In the same device, but placed perpendicular to these guides light channels fluídicos drive blood
sample.
At certain points the light intercepts fluid and the presence of 'targets' (antibodies or
antigens, depending on the case) modulates the intensity of transmitted light and there is a sign
indicating that the patient shows symptoms of the disease.
Hill explained that 'on the side walls of the channels are placed where optical receivers for the
detection of' targets', the electric field is very high and concentrated.
'Therefore, if there are' targets' on the sample to find their roots in the receivers, as his
presence changes the effective refractive index of the structure detection, the resonance
frequency was also amended effective ', has indicated.
a sensor biochemist from 'user-friendly, cost-effective and fast', which will be used to detect
various diseases simultaneously from a small sample of blood.
This was reported today by the principal investigator, Dr. Daniel Hill, who has said that the
European project SABIO (Ultrahigh sensitivity Slot-wAveguide BIOsensor on a highly integrated
chip for simultaneous diagnosis of multiple diseases) is part of the Sixth Framework Programme,
began in January 2006 and lasts for three years.
The investigator stated that the objective of the research is to be able to detect any health
center or hospital Hepatitis B and C, citomeglovirus and liver cancer fast reliable without
having to send the sample to a laboratory , thus saving money and energy.
Daniel Hill, the project coordinator, has indicated that it only requires a simple drop of blood
and waiting for minutes to get the results.
In addition, this instrument will be compact and automated, thus easy to handle for a person with
little technical knowledge.
The 'box' or platform where the sample is introduced, incorporating the different components that
research units involved in SABIO have developed, primarily a chip photonics, a system to control
entry and exit lighting, anti-vibration system and another control the temperature, and that any
alteration of conditions can affect the outcome.
The chip that analyzes the sample is composed of components of nanometer size (1 millimeter =
which explains that with a single drop of blood will be able to obtain
reliable results.
Moreover, compared with the sensors currently available on the market, this device includes many
more areas of detection, thus generates a lot of data points which translates into greater
sensitivity in the measurement of a greater number of diseases with a sample small.
'There is no technology that can do so many tests in an area so small,' said Daniel Hill.
By reducing the sample, also reduces the amount of reagents used thereby lowering the process.
The design of the chip or biochemical sensor is the most complex.
It's made with silicon, the same material which manufactured electronic microchips phones or
computers, but transmits light rather than electricity.
This is possible thanks to the incorporation of a series of nanoguías light or 'guides slotted'
(slot-waveguides) that channel light.
In the same device, but placed perpendicular to these guides light channels fluídicos drive blood
sample.
At certain points the light intercepts fluid and the presence of 'targets' (antibodies or
antigens, depending on the case) modulates the intensity of transmitted light and there is a sign
indicating that the patient shows symptoms of the disease.
Hill explained that 'on the side walls of the channels are placed where optical receivers for the
detection of' targets', the electric field is very high and concentrated.
'Therefore, if there are' targets' on the sample to find their roots in the receivers, as his
presence changes the effective refractive index of the structure detection, the resonance
frequency was also amended effective ', has indicated.
Affects between the population and cause
The pain focuses up to of the consultations which were attended by doctors Primary Care
reason which causes up to of patients suffer depression as a result of it, because this is a
factor that "deteriorates quality of life. "
EUROPE PRESS This was stressed today in a press conference the head of the Task Force of pain of
the Spanish Society of Primary Care Physicians , Emilio Blanco, on the occasion of the
celebration of the Jornadas national treatment of pain, which meet between today and
about doctors in Santiago.
According commented Dr. White, who serves as medical family in Valladolid, people who have pain
"must always consult a doctor." "There are people who do afternoon," said, pointing out that
"sometimes feel fear and can make is to prolong the suffering".
Thus, he stressed that in the case of chronic pain "be consulted as soon as possible and catch up
treatment will be better forever. In this vein, the president of Galicia and Semergen-doctor at
the health center Pilgrim Virgin of Pontevedra, Isidore Rivera, insisted that the pain "has the
potential to alleviate."
Therefore, Rivera said that these days claim that family doctors "know, forming and always treat
pain." Thus, invited physicians to convey that "there are solutions" because "is not something
that has to happen." "The stoicism in the twenty-first century should not exist", he said the
president-elect of the Spanish Society of Pain and head of the Pain Unit of the Hospital
Architect Marcide Ferrol, Manuel Camba.
EUTANASIA.
Along these lines, Dr. Camba acknowledged that "it is a problem getting a relief of 100% and in
cases such as neuropathic pain - which suffers from a" very strong "and" continuing ", as
explained Emilio Blanco -- , "only reaches 30-40%" of relief. However, Manuel Camba stressed that
"there are technical enough to deal with any type of pain."
"Sometimes reaching suicide because it is unbearable," admitted the head of the Pain Unit at
Hospital Marcide Architect. However, he stressed that "in " failed "never a request for
euthanasia."
Thus, Camba said that the first professionals "will receive the patient" is the Primary Care
doctors, who "should get the first treatment of pain." These optional addressed in the health
care field to 84% with pain.
In addition, he pointed out that psychiatrists and psychologists working with these optional
units pain, which have all hospitals Galicians.
The overall objective of the meeting, which was developed through eight workshops as a practical
matter, it focuses on improving the training of family doctor to evaluate and treat "an efficient
and coordinated manner" with the other levels of health care patients they show any kind of pain.
According to the data, it is estimated that in Spain of the population consume analgesics
routinely, headache being the main reason.
This third edition, following the two previous meetings in Barcelona and Valladolid, includes
workshops "practical and interactive" in which cases will be dealt with and all involved two
rapporteurs, of whom at least one shall be a family physician.
The themes of the workshops will be neuropathic pain, oncology, antiflamatorios, pain and
depression, osteoarthritis - prevalent disease in adulthood which is not less than 20% of
consultations - fibromyalgia - affects between the population and cause a
deterioration of the quality of life - acute pain and headaches - considered one of the most
common and disabling diseases -.
reason which causes up to of patients suffer depression as a result of it, because this is a
factor that "deteriorates quality of life. "
EUROPE PRESS This was stressed today in a press conference the head of the Task Force of pain of
the Spanish Society of Primary Care Physicians , Emilio Blanco, on the occasion of the
celebration of the Jornadas national treatment of pain, which meet between today and
about doctors in Santiago.
According commented Dr. White, who serves as medical family in Valladolid, people who have pain
"must always consult a doctor." "There are people who do afternoon," said, pointing out that
"sometimes feel fear and can make is to prolong the suffering".
Thus, he stressed that in the case of chronic pain "be consulted as soon as possible and catch up
treatment will be better forever. In this vein, the president of Galicia and Semergen-doctor at
the health center Pilgrim Virgin of Pontevedra, Isidore Rivera, insisted that the pain "has the
potential to alleviate."
Therefore, Rivera said that these days claim that family doctors "know, forming and always treat
pain." Thus, invited physicians to convey that "there are solutions" because "is not something
that has to happen." "The stoicism in the twenty-first century should not exist", he said the
president-elect of the Spanish Society of Pain and head of the Pain Unit of the Hospital
Architect Marcide Ferrol, Manuel Camba.
EUTANASIA.
Along these lines, Dr. Camba acknowledged that "it is a problem getting a relief of 100% and in
cases such as neuropathic pain - which suffers from a" very strong "and" continuing ", as
explained Emilio Blanco -- , "only reaches 30-40%" of relief. However, Manuel Camba stressed that
"there are technical enough to deal with any type of pain."
"Sometimes reaching suicide because it is unbearable," admitted the head of the Pain Unit at
Hospital Marcide Architect. However, he stressed that "in " failed "never a request for
euthanasia."
Thus, Camba said that the first professionals "will receive the patient" is the Primary Care
doctors, who "should get the first treatment of pain." These optional addressed in the health
care field to 84% with pain.
In addition, he pointed out that psychiatrists and psychologists working with these optional
units pain, which have all hospitals Galicians.
The overall objective of the meeting, which was developed through eight workshops as a practical
matter, it focuses on improving the training of family doctor to evaluate and treat "an efficient
and coordinated manner" with the other levels of health care patients they show any kind of pain.
According to the data, it is estimated that in Spain of the population consume analgesics
routinely, headache being the main reason.
This third edition, following the two previous meetings in Barcelona and Valladolid, includes
workshops "practical and interactive" in which cases will be dealt with and all involved two
rapporteurs, of whom at least one shall be a family physician.
The themes of the workshops will be neuropathic pain, oncology, antiflamatorios, pain and
depression, osteoarthritis - prevalent disease in adulthood which is not less than 20% of
consultations - fibromyalgia - affects between the population and cause a
deterioration of the quality of life - acute pain and headaches - considered one of the most
common and disabling diseases -.
Subscribe to:
Posts (Atom)
